Gene · 28874
Papers2,209
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,209
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Competition of Yin and Yang: Exploring the Role of Wild-Type and Mutant p53 in Tumor Progression. | Biomedicines | 2023 | 37189810 | PubTator, text mining | PubMed |
| Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus. | Mol Ther Nucleic Acids | 2023 | 37187708 | PubTator, text mining | PubMed |
| Integrins and the Metastasis-like Dissemination of Acute Lymphoblastic Leukemia to the Central Nervous System. | Cancers (Basel) | 2023 | 37173970 | PubTator, text mining | PubMed |
| Lamin Filament Assembly Derived from the Atomic Structure of the Antiparallel Four-Helix Bundle. | Mol Cells | 2023 | 37170772 | PubTator, text mining | PubMed |
| ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics. | Acta Neuropathol Commun | 2023 | 37158955 | PubTator, text mining | PubMed |
| FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma. | Aging (Albany NY) | 2023 | 37155154 | PubTator, text mining | PubMed |
| Elucidating the Role of Noncovalent Interactions in Favipiravir, a Drug Active against Various Human RNA Viruses; a 1H-14N NQDR/Periodic DFT/QTAIM/RDS/3D Hirshfeld Surfaces Combined Study. | Molecules | 2023 | 37110542 | PubTator, text mining | PubMed |
| Controlling Amyloid Beta Peptide Aggregation and Toxicity by Protease-Stable Ligands. | ACS Bio Med Chem Au | 2023 | 37101809 | PubTator, text mining | PubMed |
| PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma. | Front Mol Biosci | 2023 | 37101558 | PubTator, text mining | PubMed |
| Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation. | Acta Neuropathol Commun | 2023 | 37087498 | PubTator, text mining | PubMed |
| Structural and functional properties of a plant NRAMP-related aluminum transporter. | Elife | 2023 | 37074929 | PubTator, text mining | PubMed |
| KIR-HLA interactions extend human CD8+ T cell lifespan in vivo. | J Clin Invest | 2023 | 37071474 | PubTator, text mining | PubMed |
| The progress of microenvironment-targeted therapies in brain metastases. | Front Mol Biosci | 2023 | 37056723 | PubTator, text mining | PubMed |
| Structural polymorphism and cytotoxicity of brain-derived β-amyloid extracts. | Protein Sci | 2023 | 37051675 | PubTator, text mining | PubMed |
| A Rare Case of Suspected Neuronal Intranuclear Inclusion Disease Requiring Differentiation From Neuro-Behçet's Disease. | Cureus | 2023 | 37038582 | PubTator, text mining | PubMed |
| Quantitative proteomics analysis in small cell carcinoma of cervix reveals novel therapeutic targets. | Clin Proteomics | 2023 | 37031178 | PubTator, text mining | PubMed |
| GDNF family receptor alpha-like antagonist antibody alleviates chemotherapy-induced cachexia in melanoma-bearing mice. | J Cachexia Sarcopenia Muscle | 2023 | 37017344 | PubTator, text mining | PubMed |
| Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants. | Cell Discov | 2023 | 37015915 | PubTator, text mining | PubMed |
| Malondialdehyde-Induced Post-Translational Modification of Human Hemoglobin. | J Proteome Res | 2023 | 37014105 | PubTator, text mining | PubMed |
| Copper overload impairs hematopoietic stem and progenitor cell proliferation via prompting HSF1/SP1 aggregation and the subsequently downregulating FOXM1-Cytoskeleton axis. | iScience | 2023 | 37009226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28874/papers?page=7